Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for japanese patients with stubborn lymphoma?

NCT ID NCT04533581

Ongoing Disease control Sponsor: Kyowa Kirin Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 33 times

Summary

This study tests an experimental drug called ME-401 in 61 Japanese adults with a type of slow-growing blood cancer (indolent B-cell non-Hodgkin's lymphoma) that has come back or not responded to at least two prior treatments. The main goal is to see how many patients' tumors shrink or disappear. This is a disease-control study, not a cure, as ongoing management is expected.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INDOLENT B-CELL NON-HODGKIN'S LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aichi Cancer Center Hospital

    Nagoya, Aichi-ken, Japan

  • Akita University Hospital

    Akita, Japan

  • Anjo Kosei Hospital

    Anjo, Aichi-ken, Japan

  • Aomori Prefectural Central Hospital

    Aomori, Japan

  • Chiba Cancer Center

    Chiba, Japan

  • Chugoku Central Hospital

    Fukuyama, Hiroshima, Japan

  • Gunma University Hospital

    Maebashi, Gunma, Japan

  • Hokkaido University Hospital

    Sapporo, Hokkaido, Japan

  • Ishikawa Prefectural Central Hospital

    Kanazawa, Ishikawa-ken, Japan

  • Japanese Red Cross Kyoto Daini Hospital

    Kyoto, Japan

  • Japanese Red Cross Nagoya Daini Hospital

    Nagoya, Aichi-ken, Japan

  • Jichi Medical University Hospital

    Shimotsuke, Tochigi, Japan

  • Kagoshima University Hospital

    Kagoshima, Japan

  • Kameda Medical Center

    Kamogawa, Chiba, Japan

  • Kindai University Hospital

    Sayama, Osaka, Japan

  • Kurashiki Central Hospital

    Kurashiki, Okayama-ken, Japan

  • Kyushu University Hospital

    Fukuoka, Japan

  • Mie University Hospital

    Tsu, Mie-ken, Japan

  • National Cancer Center Hospital

    Chuo-ku, Tokyo, Japan

  • National Hospital Organization Kumamoto Medical Center

    Kumamoto, Japan

  • National Hospital Organization Kyushu Medical Center

    Fukuoka, Japan

  • National Hospital Organization Nagoya Medical Center

    Nagoya, Aichi-ken, Japan

  • National Hospital Organization Shikoku Cancer Center

    Matsuyama, Ehime, Japan

  • Okayama University Hospital

    Okayama, Japan

  • Osaka University Hospital

    Suita, Osaka, Japan

  • Saitama Medical University International Medical Center

    Hidaka, Saitama, Japan

  • The Cancer Institute Hospital Of JFCR

    Koto-ku, Tokyo, Japan

  • Tohoku University Hospital

    Sendai, Miyagi, Japan

  • Tokyo Metropolitan Komagome Hospital

    Bunkyo-ku, Tokyo, Japan

  • Tottori University Hospital

    Yonago, Tottori, Japan

Conditions

Explore the condition pages connected to this study.

INDOLENT B-CELL NON-HODGKIN'S LYMPHOMA